Optimizing PrEP in Practice: Guidelines & Clinical Considerations

How do the latest CDC’s Clinical Practice PrEP Guidelines affect you, your patients, and your practice? 

PrEP is a vital tool in our efforts to End the HIV Epidemic in the US. In December 2021, CDC published the Clinical Practice Guideline for Preexposure Prophylaxis for HIV Prevention and Clinical Providers Supplement. This document serves as a guidepost for data-driven PrEP delivery and reflects the latest evidence and FDA guidance for PrEP prescribing, the policy implications on newly FDA-approved long-acting products, and the multiple ways in which patients are onboarded.

Dr. Demetre Daskalakis, CDC’s Director of the Division of HIV Prevention, delves into these clinical guidelines and reviews the latest PrEP science. Following his presentation, Dr. Anu Hazra will speak to the clinical considerations of the guidelines from a PrEP provider standpoint.

Faculty:

Demetre C. Daskalakis, MD, MPH, Director, Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention

Anu Hazra, MD, Assistant Professor, Section of Infectious Diseases & Global Health; Director of STI Services, Chicago Center of HIV Elimination; Medical Director, DCAM Sexual Wellness Clinic; University of Chicago Medicine; Howard Brown Health Center

Related Trainings

Opportunities and Strategies to Optimize PrEP Uptake in Key Communities

This interactive webinar featured the perspectives of multiple diverse HIV prevention experts on PrEP uptake among relevant consumer/patient communities, including Black women, same-gender-loving (SGL) Black and Latino men, and transgender individuals.

Learn More

Improving Patient-Provider Relationships with LGBTQ Patients Living with HIV

Join HealthHIV and Kathleen A. McManus, MD, MSCR, MSDC, FIDSA with the University of Virginia for an interactive webinar to discuss strategies for empowering providers to deliver affirming and comprehensive care for LGBTQ patients living with HIV.

Learn More